HuGE Literature Finder
Records
1
-
5
Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis. Medicine 2021 Mar 100 (10): e19713. Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa |
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis. Thoracic cancer 2021 Feb . Kobayashi Nobuaki, Katakura Seigo, Kamimaki Chisato, Somekawa Kohei, Fukuda Nobuhiko, Tanaka Katsushi, Watanabe Keisuke, Horita Nobuyuki, Hara Yu, Piao Hongmei, Kaneko Takes |
A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes. Journal of thoracic disease 2017 Aug 9 (8): 2560-2571. Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang |
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jan 26 (1): 13-21. Sorich M J, Wiese M D, Rowland A, Kichenadasse G, McKinnon R A, Karapetis C |
KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis. Cancer 2013 Feb 119 (4): 714-21. Mao Chen, Huang Ya-Fang, Yang Zu-Yao, Zheng Da-Yong, Chen Jin-Zhang, Tang Jin-Li |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: